Baseline characteristics of control and intervention group patients
| Control group(N = 45) | Intervention group(N = 47) | Total(N = 92) | |
|---|---|---|---|
| Data presented as numbers (%) unless stated otherwise. | |||
| Sociodemographic/economic characteristics | |||
| Female sex | 38 (84) | 29 (62) | 67 (73) |
| Mean (SD) age (years) | 34.7 (10.2) | 38.2 (11.1) | 36.5 (10.7) |
| White ethnic background | 45 (100) | 45 (96) | 90 (98) |
| Living in adverse family circumstances(currently divorced/separated/single parent) | 13 (29) | 15 (32) | 28 (30) |
| Left full time education aged ⩽16 years | 28 (64) | 40 (85) | 68 (75) |
| Currently employed outside the home | 17 (38) | 20 (43) | 37 (40) |
| Net family income <£300 per week | 28 (64) | 34 (72) | 62 (68) |
| Household in receipt of welfare benefits(including child benefit) | 40 (89) | 39 (83) | 79 (86) |
| Living in public housing | 16 (36) | 19 (40) | 35 (38) |
| Clinical characteristics | |||
| Mean (SD) years with asthma | 20.5 (12.0) | 23.0 (10.6) | 21.8 (11.3) |
| Admission or accident and emergency attendance for asthma in prior 6 months | 17 (38) | 29 (62) | 46 (50) |
| Median (IQR) daily dose of inhaled β agonist (μg) | 1250 (4975) | 1100 (5600) | 1250 (5150) |
| Median (IQR) daily dose of inhaled steroids (μg beclometasone equivalent) | 2000 (2000) | 2000 (3000) | 2000 (2475) |
| Currently taking oral steroids | 24 (53) | 26 (55) | 50 (54) |
| Taking other (non-asthma) medications | 38 (84) | 34 (72) | 72 (78) |
| Reaching HADS score for moderate to severe anxiety (11+) | 16 (36) | 17 (36) | 33 (36) |
| Reaching HADS score for moderate to severe depression (11+) | 5 (11) | 8 (17) | 13 (14) |
| Reaching GHQ-12 score for possible psychiatric caseness (6+) | 13 (29) | 17 (36) | 30 (33) |